- Home
- » Tags
- » Vincristine
Top View
- Chemotherapy Extravasation Management
- Evolution of Nitrogen-Based Alkylating Anticancer Agents
- In Vitro and in Vivo Characterization of Doxorubicin and Vincristine
- MS-209, a Quinoline-Type Reversal Agent, Potentiates Antitumor Efficacy of Docetaxel in Multidrug-Resistant Solid Tumor Xenograft Models1
- Animal Models of Chemotherapy-Evoked Painful Peripheral Neuropathies
- Estramustine Phosphate Induces PC3 Apoptosis in Prostate Cancer Occurrence and Development
- Pharmacokinetics of Vincristine Monotherapy in Childhood Acute Lymphoblastic Leukemia
- HOPA News Volume 10, Issue 1
- Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
- Hospira UK Ltd Queensway, Royal Leamington Spa, Warwickshire
- BC Cancer Protocol Summary for Etoposide, Ifosfamide-Mesna
- Effects of Vincristine in Combination with Methotrexate and Other Antitumor Agents in Human Acute Lymphoblastic Leukemia Cells in Culture1
- Full Text (PDF)
- RCEOP-Cyclophosphamide-Etoposide-Prednisolone-Rituximab-Vincristine Ver
- Neulasta and Pegfilgrastim Biosimilars 1931-A SGM P2020 © 2020 CVS Caremark
- 1 Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor
- Schedule-Dependent Synergism and Antagonism Between Methotrexate
- Optimum Time Sequence for the Administration of Vincristine and Cyclophosphamide in Vivo1
- Establishment of a Novel in Vitro Model for Predicting Incidence and Severity of Microtubule-Targeting Agent-Induced Peripheral Neuropathy
- How LLS Is Changing the Landscape of Blood Cancer
- Pharmacy Policy Statement
- Chemotherapy Protocol
- Arsenic Trioxide Utilization Review Medical Policy • Arsenic Trioxide Injection for Intravenous Use (Trisenox® – Teva Pharmaceuticals, Generics)
- Structural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer Drugs
- Inhibition of Malignant Glial Cell Growth by Estramustine, an Estrogen
- Vincristine and Vinblastine a Review
- Sarcoma and Pnet
- The Molecular Mechanisms of Human Osteosarcoma Cell Apoptosis
- Vincristine Sulfate Injection
- Inp RCODOX M(66) Cyclophosphamide Doxorubicin Methotrexate Rituximab Vincristine
- Cyclophosphamide, Doxorubicin and Vincristine (CAV)
- Antiinvasive Activity of Estramustine on Malignant MO4 Mouse Cells and on DU-145 Human Prostate Carcinoma Cells in Vitro1
- Characteristics of Non-Randomized Studies Using Comparisons with External Controls Submitted for Regulatory Approval in the Us and Europe: a Systematic Review
- High-Dose Methotrexate-Based Regimens and Post-Remission
- Vincristinesulfatempinj.Pdf
- Peripheral Neuropathy Under Oncologic Therapies: a Literature Review on Pathogenetic Mechanisms
- Therapeutic Potential of Arsenic Trioxide with Or Without Interferon-Α
- Gynaecomastia: Aetiology and Treatment Options
- Clinical Activity of Arsenic Trioxide in Burkitt-Like Lymphoma 271
- 203469Orig1s000
- Cyclophosphamide, Doxorubicin, Vincristine
- Patient Information Leaflet
- Liposome-Encapsulated Vincristine, Vinblastine and Vinorelbine: a Comparative Study of Drug Loading and Retention
- Vincristine Sulfate Rx Only Injection, USP
- Treating Chronic Myeloid Leukemia If You’Ve Been Diagnosed with Chronic Myeloid Leukemia (CML), Your Treatment Team Will Discuss Your Options with You
- Comparison of the Effects of Vinblastine, Vincristine, Vindesine, and Vinepidine on Microtubule Dynamics and Cell Proliferation in Vitro
- Repoch - Cyclophosphamide-Doxorubicin-Etoposide-Prednisolone- Rituximab-Vincristine
- Trisenox® (Arsenic Trioxide) Last Revised Date: 03/18/2021 Arsenic Trioxide Injection